1-Week Weakening Healthcare Stocks
1-Week Weakening Healthcare Stocks
1-Week Weakening Healthcare Stocks: Northwest Biotherapeutics Inc (NASDAQ:NWBO), MiMedx Group Inc (NASDAQ:MDXG), PDL BioPharma Inc (NASDAQ:PDLI)
Read more at WSObserver.com
It is a good feeling — and good for your portfolio value — when the share price of a stock you own goes up in value. As an investor, it is helpful to keep up with the percentage gains on different stocks. Calculating the percentage increase of a stock is a quick and simple process.
Percent increase and percent decrease are measures of percent change, which is the extent to which a variable gains or losses intensity, magnitude, extent, or value. The figures are arrived at by comparing the initial (or before) and final (or after) quantities according to a specific formula. It is assumed that both the initial and the final quantities are positive (larger than 0).
Northwest Biotherapeutics, Inc (NASDAQ:NWBO), latest closing price of $4.19 is at a discount to its 200-day moving average price of $8.78. Its 52-week range has been $3.82 – $12.55; it is trading at discount versus its 52-week high of $12.55 achieved on Jul 23, 2015 and a premium to its 52-week low of $3.82 faced on Oct 16, 2015. The stock, as of recent close, has shown weekly downbeat performance of -31.98% which was maintained at -21.68% in this year.
MiMedx Group Inc (NASDAQ:MDXG), traded on a volume of 1.37 million, higher than its standard daily volume. Shares have lost -0.72% to $8.32. The stock, as of recent close, has shown weekly downbeat performance of -11.49% which was maintained at -27.84% in this year. Over the last twelve months, the stock faced a worst price of $7.54 on Oct 15, 2015. The stock has moved down across its 50-day moving average of $9.77.
The most recent price of PDL BioPharma Inc (NASDAQ:PDLI), is now at a discount to the 12-month high of $8.60 hit on Oct 24, 2014. The last price is at a premium to the 52-week low of $4.40 suffered on Oct 16, 2015. The stock, as of recent close, has shown weekly downbeat performance of -12.60% which was maintained at -36.14% in this year.
